CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ 121,911	$ 241,850
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation	425,635	251,716
Gain on strategic investments and marketable securities, net	(134,647)	(192,158)
Debt inducement expense	28,584	0
Depreciation and amortization	56,216	30,745
Provision for bad debts and inventory	8,828	13,824
Deferred income taxes	(53,696)	(27,061)
Other noncash items	15,930	13,183
Change in assets and liabilities:
Receivables and contract assets	(366,053)	(226,759)
Inventory	(58,177)	(11,629)
Deferred revenue	21,556	56,720
Accounts payable, accrued and other liabilities	44,730	10,243
Prepaid expenses and other assets	(116,713)	(2,528)
Net cash provided by (used in) operating activities	(5,896)	158,146
Cash flows from investing activities:
Purchases of investments	(2,045,738)	(615,414)
Business combinations, net of cash acquired	(22,809)	(237,796)
Proceeds from call, maturity, and sale of investments	1,644,556	858,326
Purchases of property and equipment	(74,450)	(53,984)
Other, net	(49)	34
Net cash used in investing activities	(498,490)	(48,834)
Cash flows from financing activities:
Net proceeds from equity offering	362,241	0
Proceeds from issuance of notes	1,750,000	0
Proceeds from options exercised	0	9,717
Principal payments for conversion of convertible debt	(407,472)	0
Payments to third-parties for debt issuance, amendment and repurchase activity	(26,888)	0
Income and payroll tax payments for net-settled stock awards	(209,631)	(22,325)
Other, net	(226)	0
Net cash provided by (used in) financing activities	1,468,024	(12,608)
Effect of exchange rate changes on cash and cash equivalents	5,741	75
Net increase (decrease) in cash and cash equivalents	969,379	96,779
Cash and cash equivalents and restricted cash, beginning of period	466,763	600,670
Cash and cash equivalents and restricted cash, end of period	1,436,142	697,449
Supplemental disclosures:
Cash and cash equivalents	1,423,871	695,144
Restricted cash	12,271	2,305
Total cash, cash equivalents and restricted cash shown in the statements of cash flows	1,436,142	697,449
Cash paid for interest	56,468	1,725
Cash paid for income taxes, net of refunds	51,608	60,670
Non-cash transactions:
Leased assets obtained in exchange for new operating lease liabilities	51,780	11,728
Expense for induced conversion of convertible debt, debt offering and revolver modification	31,570	0
Taxes withheld on stock-based awards included in accrued expenses	10,510	0
Property and equipment purchases in accounts payable and accrued liabilities	$ 3,432	$ 10,214